Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Prime Medicine (PRME) Tax Provisions: 2021-2024

Historic Tax Provisions for Prime Medicine (PRME) over the last 2 years, with Jun 2024 value amounting to -$134,000.

  • Prime Medicine's Tax Provisions fell 532.26% to -$134,000 in Q2 2024 from the same period last year, while for Jun 2024 it was -$77,000, marking a year-over-year increase of 46.90%. This contributed to the annual value of -$279,000 for FY2023, which is 70.57% up from last year.
  • Per Prime Medicine's latest filing, its Tax Provisions stood at -$134,000 for Q2 2024, which was down 200.00% from $134,000 recorded in Q1 2024.
  • In the past 5 years, Prime Medicine's Tax Provisions registered a high of $1.4 million during Q4 2021, and its lowest value of -$2.4 million during Q3 2021.
  • Over the past 3 years, Prime Medicine's median Tax Provisions value was -$134,000 (recorded in 2024), while the average stood at -$136,333.
  • Over the last 5 years, Prime Medicine's Tax Provisions had its largest YoY gain of 166.34% in 2024, and its largest YoY loss of 532.26% in 2024.
  • Prime Medicine's Tax Provisions (Quarterly) stood at $1.4 million in 2021, then plummeted by 113.61% to -$186,000 in 2022, then crashed by 150.94% to -$108,000 in 2023, then plummeted by 532.26% to -$134,000 in 2024.
  • Its Tax Provisions was -$134,000 in Q2 2024, compared to $134,000 in Q1 2024 and -$108,000 in Q3 2023.